down arrow

Profound Medical Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA74319B5027
CAD
9.31
0.76 (8.89%)

Dec 04

TSE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

9.309.72

52 Week

5.2311.62
Valuation
Technical
Day's Volume

CASH

36.99 k

Shareholding (Mar 2025)

FII

29.14%

Held by 72 FIIs

DII

63.28%

Held by 9 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

  • NET SALES(Q) At CAD 3.06 MM has Fallen at -25.91%
  • OPERATING CASH FLOW(Y) Lowest at CAD -48.56 MM
  • ROCE(HY) Lowest at -106.37%
2

Risky -

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 231 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.78

stock-summary
Return on Equity

-106.03%

stock-summary
Price to Book

4.32

Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
-22 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
53.38%
0%
53.38%
6 Months
22.34%
0%
22.34%
1 Year
-20.5%
0%
-20.5%
2 Years
-35.12%
0%
-35.12%
3 Years
31.31%
0%
31.31%
4 Years
-35.03%
0%
-35.03%
5 Years
-60.88%
0%
-60.88%

Profound Medical Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Profound Medical Corp. Hits Day High with 8.12% Surge in Stock Price

Profound Medical Corp. Hits Day High with 8.12% Surge in Stock Price

Profound Medical Corp. has seen a significant increase in its stock price today, contrasting with the modest rise of the S&P/TSX 60 index. Despite recent gains, the company faces ongoing challenges, including a substantial decline in profits over the past year and a negative return on equity.

Read More
Profound Medical Corp. Hits Day High with Strong 8.12% Intraday Surge

Profound Medical Corp. Hits Day High with Strong 8.12% Intraday Surge

Profound Medical Corp. has seen significant short-term gains, with an 8.12% increase on November 11, 2025, and an 8.38% rise over the past week. However, the company faces long-term challenges, including a 20.75% decline over the past year and a 63.32% drop over five years.

Read More
Profound Medical Corp. Hits Day Low at CAD 7.46 Amid Price Pressure

Profound Medical Corp. Hits Day Low at CAD 7.46 Amid Price Pressure

Profound Medical Corp. has faced notable stock volatility, declining 7.06% on October 22, 2025. Despite a recent monthly increase, the company has a year-to-date drop of 29.35% and a significant five-year decline of 68.1%. Financial metrics reveal ongoing challenges in its market performance.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
20.66%
EBIT Growth (5y)
-187.67%
EBIT to Interest (avg)
-38.21
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
0.18
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
50.83%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.48
EV to EBIT
-3.36
EV to EBITDA
-3.41
EV to Capital Employed
16.54
EV to Sales
12.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-491.65%
ROE (Latest)
-106.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 6 Schemes (7.58%)

Foreign Institutions

Held by 72 Foreign Institutions (29.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -18.42% vs -34.48% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -40.91% vs -123.19% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "3.80",
          "chgp": "-18.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.90",
          "val2": "-15.80",
          "chgp": "-19.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.70",
          "val2": "-15.40",
          "chgp": "-40.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,244.20%",
          "val2": "-4,260.20%",
          "chgp": "-198.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 50.52% vs 11.49% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.26% vs -2.41% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.60",
          "val2": "9.70",
          "chgp": "50.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-44.00",
          "val2": "-37.40",
          "chgp": "-17.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-38.10",
          "val2": "-38.20",
          "chgp": "0.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,095.70%",
          "val2": "-3,979.90%",
          "chgp": "88.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
3.10
3.80
-18.42%
Operating Profit (PBDIT) excl Other Income
-18.90
-15.80
-19.62%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-21.70
-15.40
-40.91%
Operating Profit Margin (Excl OI)
-6,244.20%
-4,260.20%
-198.40%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -18.42% vs -34.48% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -40.91% vs -123.19% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
14.60
9.70
50.52%
Operating Profit (PBDIT) excl Other Income
-44.00
-37.40
-17.65%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-38.10
-38.20
0.26%
Operating Profit Margin (Excl OI)
-3,095.70%
-3,979.90%
88.42%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 50.52% vs 11.49% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 0.26% vs -2.41% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Profound Medical Corp. stock-summary
stock-summary
Profound Medical Corp.
Pharmaceuticals & Biotechnology
Profound Medical Corp. is a commercial-stage medical device company. focused on customizable, incision-free therapies which combine real-time magnetic resonance imaging (MRI), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The Company’s products include TULSA-PRO System and SONALLEVE. The TULSA-PRO is used to ablate benign or malignant prostate tissue in patients with a variety of prostate diseases. Prostate diseases include prostate cancer and benign prostatic hyperlasia (BPH). Prostate cancer is one of the common types of cancer affecting men. TULSA-PRO and SONALLEVE share the common technological concept of using MRI to enable visualization of the surgeon desired tissue in real time. Both products also use thermal ultrasound technology to heat and ablate tissue.
Company Coordinates stock-summary
Company Details
2400 Skymark Ave Unit 6 , MISSISSAUGA ON : L4W 5K5
stock-summary
Tel: 1 647 47613501 647 8724849
stock-summary
http://www.profoundmedical.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."